VanEck Pharmaceutical ETF
PPH
#1094
ETF rank
A$1.76 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$157.38
Share price
1.07%
Change (1 day)
12.63%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of February 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of February 2026: 0.36%